201 related articles for article (PubMed ID: 24792092)
1. AT2 receptors targeting cardiac protection post-myocardial infarction.
Kaschina E; Lauer D; Schmerler P; Unger T; Steckelings UM
Curr Hypertens Rep; 2014 Jul; 16(7):441. PubMed ID: 24792092
[TBL] [Abstract][Full Text] [Related]
2. Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice.
Xu J; Carretero OA; Liu YH; Shesely EG; Yang F; Kapke A; Yang XP
Hypertension; 2002 Sep; 40(3):244-50. PubMed ID: 12215461
[TBL] [Abstract][Full Text] [Related]
3. Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling.
Voros S; Yang Z; Bove CM; Gilson WD; Epstein FH; French BA; Berr SS; Bishop SP; Conaway MR; Matsubara H; Carey RM; Kramer CM
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1004-10. PubMed ID: 16214839
[TBL] [Abstract][Full Text] [Related]
4. [On angiotensin II receptor distribution after myocardial infarction in dogs].
Qu XF; Li JJ; Xi Y; Shen JX; Xiu CH; Yue L; Wang GZ; Huang YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):358-62. PubMed ID: 19791474
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin receptors alter myocardial infarction-induced remodeling of the guinea pig cardiac plexus.
Hardwick JC; Ryan SE; Powers EN; Southerland EM; Ardell JL
Am J Physiol Regul Integr Comp Physiol; 2015 Jul; 309(2):R179-88. PubMed ID: 25947168
[TBL] [Abstract][Full Text] [Related]
6. Transitory reduction in angiotensin AT2 receptor expression levels in postinfarct remodelling in rat myocardium.
Lax CJ; Domenighetti AA; Pavia JM; Di Nicolantonio R; Curl CL; Morris MJ; Delbridge LM
Clin Exp Pharmacol Physiol; 2004 Aug; 31(8):512-7. PubMed ID: 15298543
[TBL] [Abstract][Full Text] [Related]
7. Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling.
Zhu YC; Zhu YZ; Lu N; Wang MJ; Wang YX; Yao T
Clin Exp Pharmacol Physiol; 2003 Dec; 30(12):911-8. PubMed ID: 14678229
[TBL] [Abstract][Full Text] [Related]
8. Guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart.
Li Y; Saito Y; Kuwahara K; Rong X; Kishimoto I; Harada M; Adachi Y; Nakanishi M; Kinoshita H; Horiuchi M; Murray M; Nakao K
Endocrinology; 2009 Aug; 150(8):3759-65. PubMed ID: 19372206
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.
Ambrose J; Pribnow DG; Giraud GD; Perkins KD; Muldoon L; Greenberg BH
J Cardiovasc Pharmacol; 1999 Mar; 33(3):433-9. PubMed ID: 10069680
[TBL] [Abstract][Full Text] [Related]
10. Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury.
Qi Y; Li H; Shenoy V; Li Q; Wong F; Zhang L; Raizada MK; Sumners C; Katovich MJ
Exp Physiol; 2012 Jan; 97(1):89-101. PubMed ID: 21967903
[TBL] [Abstract][Full Text] [Related]
11. The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy.
D'Amore A; Black MJ; Thomas WG
Hypertension; 2005 Dec; 46(6):1347-54. PubMed ID: 16286564
[TBL] [Abstract][Full Text] [Related]
12. The CD4(+) AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function.
Skorska A; von Haehling S; Ludwig M; Lux CA; Gaebel R; Kleiner G; Klopsch C; Dong J; Curato C; Altarche-Xifró W; Slavic S; Unger T; Steinhoff G; Li J; David R
J Cell Mol Med; 2015 Aug; 19(8):1975-85. PubMed ID: 25991381
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy.
Zhu YC; Zhu YZ; Gohlke P; Stauss HM; Unger T
Am J Cardiol; 1997 Aug; 80(3A):110A-117A. PubMed ID: 9293963
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor blockade and end-organ protection.
Chung O; Unger T
Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):150S-156S. PubMed ID: 10619595
[TBL] [Abstract][Full Text] [Related]
16. AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling.
Oishi Y; Ozono R; Yoshizumi M; Akishita M; Horiuchi M; Oshima T
Life Sci; 2006 Dec; 80(1):82-8. PubMed ID: 17023005
[TBL] [Abstract][Full Text] [Related]
17. AT1 receptor blockade in experimental myocardial ischemia/reperfusion.
Jalowy A; Schulz R; Heusch G
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S129-36. PubMed ID: 9892153
[TBL] [Abstract][Full Text] [Related]
18. The renin-angiotensin system and experimental heart failure.
Wollert KC; Drexler H
Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
[TBL] [Abstract][Full Text] [Related]
19. A nonpeptide angiotensin II type 2 receptor agonist does not attenuate postmyocardial infarction left ventricular remodeling in mice.
Jehle AB; Xu Y; Dimaria JM; French BA; Epstein FH; Berr SS; Roy RJ; Kemp BA; Carey RM; Kramer CM
J Cardiovasc Pharmacol; 2012 Apr; 59(4):363-8. PubMed ID: 22157261
[TBL] [Abstract][Full Text] [Related]
20. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
Parlakpinar H; Ozer MK; Acet A
Cytokine; 2011 Dec; 56(3):688-94. PubMed ID: 21975128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
